The 2.5 mg dose is better called the low-dose starter, because it is the labeled start and now has short direct non-diabetic data behind it. Microdosing has been used for tolerability testing, metabolic-marker support, step-down protocols, and maintenance, not for proven long-term obesity outcomes
As we learned, your body naturally produces a hormone GLP-1, but pharmaceutical drugs are engineered to provide a much stronger and longer-lasting effect
Tirzepatide reduces appetite through GIP and GLP-1 receptor activation in appetite-regulating brain centers, working through physiologic satiety pathways
"We find some people are so desperate to lose weight, and they often can't afford GLP-1 medication, so they seek cheaper alternatives online
Wegovy, on the other hand, is approved as a weight loss drug